An aspergilloma (mycetoma) is a mass of fungal elements, inflammatory cells, and mucus/tissue debris which forms in a pre-existing lung cavity. It is a noninvasive type of chronic pulmonary aspergillosis. The infection can also appear in the brain, kidney, or other organs.
Aspergillosis is an infection caused by the fungus aspergillus. Aspergillomas are formed when the fungus grows in a clump in a lung cavity. The cavity is often created by a previous condition. Cavities in the lung may be caused by diseases such as:
The most common species of fungus that causes disease in humans is Aspergillus fumigatus.
Aspergillomas may produce no symptoms or cause only a mild cough at first. Over time and without treatment, however, aspergillomas can worsen the underlying chronic lung condition and possibly cause:
Aspergillosis treatments vary with the type of disease. Possible treatments include:
1. What is the current treatment for aspergilloma?
The size of the fungal mass, the patient's overall health, and the symptoms are what determine the current course of treatment for aspergilloma, a fungal infection caused by the Aspergillus species. Watchful waiting is generally advised for patients with minimal or no symptoms, along with routine imaging and clinical evaluation monitoring. Treatment options for aspergilloma may include antifungal drugs (such as voriconazole or itraconazole) to help lower the fungal burden and treat respiratory problems or coughing up blood (hemoptysis). However, these drugs may not always completely eradicate the fungus. Surgery to remove the fungal ball (aspergilloma) may be required in extreme situations. Other alternatives include embolization, which is a minimally invasive surgery that blocks the blood arteries that supply the aspergilloma in order to reduce bleeding.
2. What is the first-line treatment for aspergilloma?
Whether a patient has symptoms or not usually determines the best course of action for aspergilloma. The first line of treatment is generally conservative involving frequent monitoring for individuals who show minimal or no symptoms. Antifungal drugs like voriconazole or itraconazole may be used as the first line of treatment to help lower the fungal activity in patients exhibiting symptoms like severe hemoptysis. These drugs, however, do not always work to get rid of the fungal mass entirely. In more severe cases, surgery is often considered the first-line treatment, especially for patients at risk of life-threatening complications.
3. Is aspergilloma serious?
Yes. Aspergilloma can be dangerous, especially if it causes major or potentially fatal consequences like hemoptysis (coughing up blood). Aspergilloma can increase respiratory symptoms and worsen the course of chronic obstructive pulmonary disease (COPD) and tuberculosis in people with underlying lung diseases. The fungal mass can expand or cause repeated bleeding, but it can also stay stable for years in certain situations. In very rare cases, it can worsen and develop into chronic pulmonary aspergillosis, which calls for more intensive care. As a result, even though some aspergillomas are benign and asymptomatic, if complications develop or the condition is not addressed, it may become serious.
4. How do you remove aspergilloma?
A lobectomy or segmentectomy, which is the surgical removal of aspergilloma, involves the excision of the lung tissue that contains the fungal tumour. Patients with severe or repeated symptoms, especially those with frequent or potentially fatal hemoptysis, are typically advised to have this procedure. Considering the chances of bleeding, the process can be complicated, but because it eliminates the fungus ball entirely, it provides the most conclusive cure. By obstructing the blood vessels that supply the aspergilloma, bronchial artery embolization can be used to limit bleeding when surgery is not an option because of poor lung function or other health difficulties. While the fungal mass remains, this can help control the symptoms and lower the possibility of developing other problems.